Cargando…
Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial
OBJECTIVES: Systemic sclerosis (SSc) is an auto-immune, multi organ disease marked by severe gastrointestinal (GI) involvement and gut dysbiosis. Here, we aimed to determine the safety and efficacy of fecal microbiota transplantation (FMT) using commercially-available anaerobic cultivated human inte...
Autores principales: | Fretheim, Håvard, Chung, Brian K., Didriksen, Henriette, Bækkevold, Espen S., Midtvedt, Øyvind, Brunborg, Cathrine, Holm, Kristian, Valeur, Jørgen, Tennøe, Anders Heiervang, Garen, Torhild, Midtvedt, Tore, Trøseid, Marius, Zarè, Hasse, Lund, May Brit, Hov, Johannes R., Lundin, Knut E. A., Molberg, Øyvind, Hoffmann-Vold, Anna-Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241803/ https://www.ncbi.nlm.nih.gov/pubmed/32437393 http://dx.doi.org/10.1371/journal.pone.0232739 |
Ejemplares similares
-
Serum markers of cardiac complications in a systemic sclerosis cohort
por: Tennøe, Anders H., et al.
Publicado: (2022) -
Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohort
por: Fretheim, Håvard, et al.
Publicado: (2020) -
Systolic Dysfunction in Systemic Sclerosis: Prevalence and Prognostic Implications
por: Tennøe, Anders H., et al.
Publicado: (2019) -
Target organ expression and biomarker characterization of chemokine CCL21 in systemic sclerosis associated pulmonary arterial hypertension
por: Didriksen, Henriette, et al.
Publicado: (2022) -
Gastrointestinal symptom severity and progression in systemic sclerosis
por: van Leeuwen, Nina M, et al.
Publicado: (2022)